NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 22.99
(1.37%)
INR 22.99
(1.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 23.45 Million INR | 271.55% |
| 2022 | 6.31 Million INR | -64.97% |
| 2021 | 18.02 Million INR | -19.39% |
| 2020 | 22.35 Million INR | 204.99% |
| 2019 | 7.33 Million INR | 658.32% |
| 2018 | 966.67 Thousand INR | -44.58% |
| 2017 | 1.74 Million INR | 41.68% |
| 2016 | 1.23 Million INR | 36.63% |
| 2015 | 901.06 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.28 Million INR | 338.02% |
| 2023 Q4 | 2.34 Million INR | -78.68% |
| 2023 Q1 | 9.18 Million INR | 363.17% |
| 2023 FY | 23.45 Million INR | 271.55% |
| 2023 Q2 | 1.2 Million INR | -86.9% |
| 2023 Q3 | 11.01 Million INR | 815.79% |
| 2022 Q2 | 1.83 Million INR | -35.27% |
| 2022 FY | 6.31 Million INR | -64.97% |
| 2022 Q4 | 1.98 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | 2.84 Million INR | -50.65% |
| 2021 Q1 | - INR | 0.0% |
| 2021 Q4 | 5.75 Million INR | -48.39% |
| 2021 FY | 18.02 Million INR | -19.39% |
| 2021 Q3 | 11.15 Million INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2020 FY | 22.35 Million INR | 204.99% |
| 2020 Q4 | - INR | 0.0% |
| 2019 FY | 7.33 Million INR | 658.32% |
| 2018 FY | 966.67 Thousand INR | -44.58% |
| 2017 FY | 1.74 Million INR | 41.68% |
| 2016 FY | 1.23 Million INR | 36.63% |
| 2015 FY | 901.06 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 30.37 Million INR | 22.758% |
| Checkpoint Trends Limited | 5.02 Million INR | -366.768% |
| Everest Organics Limited | 122.26 Million INR | 80.813% |
| GUJARAT INJECT (KERALA) LTD. | 3.85 Million INR | -508.832% |
| NATURO INDIABULL LIMITED | 3.71 Million INR | -531.983% |
| Rajnish Wellness Limited | 14.94 Million INR | -56.991% |
| Rama Vision Limited | 88.37 Million INR | 73.455% |
| Vivo Bio Tech Limited | 57.03 Million INR | 58.869% |